SCHEMBL7401247

SCHEMBL7401247

FC(F)(F)c1cccc(OCCCCN2CCC(c3ccccc3)CC2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 6/20 0.58
DRD2 P14416 1/20 0.57
HTR1A P08908 1/20 0.57
HTR7 P34969 1/20 0.57
MAOB P27338 2/20 0.55
KDM4E B2RXH2 2/20 0.53
KMT2A Q03164 2/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
GAA P10253 1/20 0.53
HTT P42858 1/20 0.53
SLC6A4 P31645 2/20 0.52
MAOA P21397 1/20 0.52
LTA4H P09960 1/20 0.51
SIGMAR1 Q99720 2/20 0.50
MEN1 O00255 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5888839 0.99 HRH3 (0.57) HRH3DRD2HTR1AHTR7MAOB
SCHEMBL9311044 0.86 DRD2 (0.66) HRH3DRD2HTR1AHTR7KDM4E
SCHEMBL5888867 0.84 HRH3 (0.68) HRH3MAOBKMT2ASIGMAR1MEN1
SCHEMBL5888791 0.80 HRH3 (0.74) HRH3DRD2HTR1AMAOBKMT2A
SCHEMBL13150800 0.79 LMNA (0.74) HRH3DRD2HTR1AHTR7KDM4E
SCHEMBL7323189 0.79 HRH3 (0.57) HRH3DRD2HTR1AHTR7KDM4E
Hydrochloric Acid SCHEMBL7319312 0.78 HRH3 (0.56) HRH3DRD2HTR1AHTR7KDM4E
SCHEMBL7402917 0.77 TMEM97 (0.71) HRH3DRD2HTR1AHTR7MAOB
SCHEMBL11822283 0.76 DRD2 (0.69) DRD2HTR1AKMT2ASLC6A4SIGMAR1
SCHEMBL5888869 0.76 SIGMAR1 (0.64) HRH3DRD2HTR1AHTR7KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP claimed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP claimed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO claimed
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed